circad | circRNAs associated with diseases
 Genome LocusBuildhg19
 DiseaseProstate CancerICD-10 Malignant neoplasm of prostate (C61)
 Experimental Method
 Sample TypeTissue and cell linesComparisonPatients (median age 65 years, range 52 to 79) underwent radical prostatectomy for localized PCa (n"="62) and benign prostatic hyperplasia (n"="35) underwent transurethral resection of the prostate (TURP)
 Method for EstimationQuantitative PCR and MicroaaraysPCR Details
No Primers FoundStatisticsFold Change : Downregulated
pvalue : <0.05
Yang, Z, Qu, CB, Zhang, Y, Zhang, WF, Wang, DD, Gao, CC, Ma, L, Chen, JS, Liu, KL, Zheng, B, Zhang, XH, Zhang, ML, Wang, XL, Wen, JK, Li, W (2019). Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene, 38, 14:2516-2532.